ATE407933T1 - Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat - Google Patents

Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat

Info

Publication number
ATE407933T1
ATE407933T1 AT06010476T AT06010476T ATE407933T1 AT E407933 T1 ATE407933 T1 AT E407933T1 AT 06010476 T AT06010476 T AT 06010476T AT 06010476 T AT06010476 T AT 06010476T AT E407933 T1 ATE407933 T1 AT E407933T1
Authority
AT
Austria
Prior art keywords
paroxetine hydrochloride
hydrochloride hemihydrate
hemihydrate
crystalline
producing paroxetine
Prior art date
Application number
AT06010476T
Other languages
English (en)
Inventor
Franca Segnalini
Stefano Magnanti
Original Assignee
Apotecnia S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotecnia S A filed Critical Apotecnia S A
Application granted granted Critical
Publication of ATE407933T1 publication Critical patent/ATE407933T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06010476T 2005-05-26 2006-05-22 Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat ATE407933T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68523705P 2005-05-26 2005-05-26

Publications (1)

Publication Number Publication Date
ATE407933T1 true ATE407933T1 (de) 2008-09-15

Family

ID=36969441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06010476T ATE407933T1 (de) 2005-05-26 2006-05-22 Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat

Country Status (4)

Country Link
EP (1) EP1726591B1 (de)
JP (1) JP2007008918A (de)
AT (1) ATE407933T1 (de)
DE (1) DE602006002650D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100797983B1 (ko) * 2006-11-01 2008-01-24 정태석 통행요금 수납장치 및 이를 이용한 수납시스템
EP2508523B2 (de) † 2007-10-23 2019-04-17 Teva Pharmaceutical Industries Ltd. Dasatinib-Polymorphe und Verfahren zu ihrer Herstellung
JP2010260826A (ja) * 2009-05-08 2010-11-18 Sumitomo Chemical Co Ltd パロキセチン塩酸塩半水和物の製造方法
CN112641750A (zh) * 2021-01-12 2021-04-13 江苏睿实生物科技有限公司 一种盐酸帕罗西汀片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9920147D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
IL162458A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
CA2496726A1 (en) * 2002-09-19 2004-04-01 Sumitomo Chemical Company, Limited Methods of crystal precipitation
WO2007054978A2 (en) * 2005-11-10 2007-05-18 Jubilant Organosys Limited Process for preparing paroxetine hydrochloride hemihydrate

Also Published As

Publication number Publication date
EP1726591A2 (de) 2006-11-29
EP1726591B1 (de) 2008-09-10
JP2007008918A (ja) 2007-01-18
EP1726591A3 (de) 2007-07-25
DE602006002650D1 (de) 2008-10-23

Similar Documents

Publication Publication Date Title
ATE544754T1 (de) Verfahren zur herstellung von ivabradinhydrochlorid
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
EP1672077A4 (de) Verfahren zur herstellung von bernsteinsäure
WO2005095379A3 (en) Crystalline methanesulfonic acid addition salts of imatinib
ATE550312T1 (de) Verfahren zur herstellung von 3,3,3- trifluorpropyn
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
EP1748076A4 (de) Verfahren zur herstellung von hydroxycarbonsäure
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
DE50307242D1 (de) Verfahren zum herstellen von einkristallinen strukturen
ATE439840T1 (de) Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
DE60304119D1 (de) Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ATE407933T1 (de) Verfahren zur herstellung von paroxetin hydrochlorid hemihydrat
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
DE602004020916D1 (de) Verfahren zum Herstellen von hochreinem Hafnium
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
IL176722A0 (en) Method of producing salts of dinitramidic acid
MA28704B1 (fr) Procede de production d'acide phosphorique
ATE469149T1 (de) Verfahren zur herstellung von cabergolin
ATE541838T1 (de) Neue zur synthese von s- und r-omeprazol geeignete verbindungen und ein verfahren zu deren herstellung
DE60123334D1 (de) Methode für die Produktion von Nukleotiden durch Fermentierung
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ITMI20051970A1 (it) Processo per la preparazione di eteri misti derivanti dall'inaftolo e intermedi di forme cristalline definite di + e - duloxetina
ATE523490T1 (de) Verfahren zur herstellung von pleuromutilinen
AU2003299300A1 (en) METHOD FOR THE PRODUCTION OF R-Alpha-LIPOIC ACID BY FERMENTATION

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties